An open controlled clinical study to evaluate efficacy of Sariwadi Yoga in early diabetic kidney disease with special reference to microalbuminurea

Valid informed written consent will be taken in the language best understood by the patient

PLAN OF ACTION : Screening and selection of the patients will be carried out as per inclusion and exclusion criteria. -> Screening for selection criteria Included for Study Written Informed consent Randomization (Statistician provided random allocation)  into 2 groups  Group A  = Study Group ,Group B =, Placebo group

Follow up every 30 days with Close observation of symptoms and AE if any Completion after 3 months

Statistical analysis with Appropriate test and Interpretation of Result

Treatment schedule : group A : standard care  (OHA/Insulin, Statin, Anti hypertensive, RAS blockers)+ Saariwadi yoga

Group B : standard care + placebo drug (OHA/Insulin, Statin Anti hypertensive, RAS blockers Explanation for Insulin therapy in standard care

Trial Drug: Sariwadi Yoga 4 gm per day

control  drug crystallline methyi cellulose

Drug will be dispenced to the patients for the period of three months free of cost

patients will be evaluated clinically every week

and laboratorical investigations will be done before screening an at the end of 3 monthsafter completion of study parametric data ( 24 hr urine micro albuminurea urine/creatinine ratio/sr creatinine ) will be analysed within the group and between the groups  with students T test . and then conclusion will be drawn considering p value.p